losmapimod

Fulcrum stock slumps after muscle disorder drug fails in late-stage study
Reuters
Thu, 09/12/24 - 11:38 am
Fulcrum Therapeutics
facioscapulohumeral muscular dystrophy
clinical trials
losmapimod
Sanofi pays $80M to add Roche-rivaling Fulcrum drug to phase 3 rare disease pipeline
Fierce Biotech
Mon, 05/13/24 - 11:25 am
Sanofi
Fulcrum Therapeutics
Roche
GSK
Rare Diseases
clinical trials
losmapimod
Fulcrum under pressure on underwhelming losmapimod data in type of muscular dystrophy
Seeking Alpha
Tue, 08/11/20 - 11:39 am
Fulcrum Therapeutics
clinical trials
losmapimod
FSHD
GSK punts a failed cardio drug to a biotech startup — which has a new development strategy in mind
Endpoints
Tue, 04/23/19 - 12:07 pm
GSK
losmapimod
Fulcrum Therapeutics
Glaxo faces another cardio R&D failure for a lead candidate
BioPharma Dive
Wed, 10/28/15 - 02:55 pm
GSK
R&D
losmapimod
GSK starts phase III of coronary drug test
Reuters
Thu, 06/5/14 - 12:10 pm
GSK
losmapimod
acute coronary syndrome